Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical pentosan polysulfate sodium for seasonal allergic rhinitis (phase 2 crossover trial)
2016-003341-28Phase 2Completed
- Sponsor
- Paradigm Biopharmaceuticals
- Start
- Sep 2016
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of pentosan polysulfate sodium in seasonal allergic rhinitis (SAR) (2 arms), sponsored by Paradigm Biopharmaceuticals. Primary endpoint: Mean post-challenge TNSS over treatment days 12–14. Started Sep 2016; status: completed.
02
Drugs
pentosan polysulfate sodium
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on 2016-003341-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-003341-28.